CPT code 95930: Visual evoked potential, central visual pathway2026 Medicare rate & RVUs in New Jersey
Reports visual evoked potential testing that records responses along the visual pathway to help evaluate suspected optic nerve or central visual pathway dysfunction.
Medicare pays $73.45–$77.49 for 95930 in the office in New Jersey, from Rest of New Jersey to Northern New Jersey. Which amount applies depends on the service address.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What 95930 covers
A visual evoked potential study records electrical responses generated as visual stimuli travel from the eyes through the optic nerves and central visual pathways. Pattern-reversal stimulation is commonly used. Neurologists, neuro-ophthalmologists, and ophthalmologists may order the test when evaluating suspected optic neuritis, demyelinating disease, or unexplained visual dysfunction. Testing is performed in an office or hospital setting using recording equipment and appropriately trained staff.
Report 95930 for the visual evoked potential service, including interpretation and report. The global service includes both the technical work, such as equipment and staff, and the professional interpretation; modifier 26 identifies the professional component, while modifier TC identifies the technical component. Documentation should support the visual stimulus and responses obtained, the interpretation, and the clinical question addressed. The code is priced as bilateral, so modifier 50 does not increase payment.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where 95930 pays more and less in New Jersey
| Payment locality | Office | Facility |
|---|---|---|
| Northern New Jersey | $77.49 | Unavailable |
| Rest of New Jersey | $73.45 | Unavailable |
How the 95930 rate is calculated
Each of 95930’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · 95930
RVUs × geographic indexes × conversion factor
Work0.34
0.34 RVUs× 1.000 GPCI
Practice expense1.67
1.67 RVUs× 1.000 GPCI
Malpractice0.02
0.02 RVUs× 1.000 GPCI
Adjusted RVUs
2.0300
Conversion factor
$33.4009
Medicare rate
$67.80
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for 95930
The CMS indicators that decide how 95930 is paid alongside other services.
CMS payment indicators · 95930
Visual evoked potential, central visual pathway
| Rule | CMS value | What it means |
|---|---|---|
| Global period | XXX | The global surgery concept doesn’t apply. |
| Multiple procedures | 0 | No multiple-procedure reduction. |
| Bilateral (modifier 50) | 2 | Already bilateral by definition: paid once at 100%. |
| Assistant at surgery (80/81/82/AS) | 0 | Not paid without supporting documentation. |
| Co-surgeons (62) | 0 | Not permitted. |
| Team surgery (66) | 0 | Not permitted. |
| Professional/technical | 1 | Diagnostic test with separate professional (26) and technical (TC) components. |
What modifiers do to the payment
Modifier 26 · payment effect
With and without the modifier
95930 without 26 · national office
$67.80
Visual evoked potential, central visual pathway
95930-26 · Professional component
$18.04
Pays only the interpretation and report.
95930 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- 95925Evoked potentialUpper limbs
- 95925 evaluates somatosensory responses associated with upper-limb stimulation; 95930 evaluates responses along the visual pathway.
- 95926Somatosensory testingLower-limb short latency
- 95926 evaluates somatosensory responses associated with lower-limb stimulation. Choose 95930 when the study tests visual pathway responses.
- 95928Motor evoked potentialsUpper limbs
- 95928 evaluates central motor responses involving the upper limbs, rather than responses to visual stimulation reported with 95930.
95930 billing questions
When should 95930 be chosen over somatosensory evoked potential codes?
Use 95930 for testing visual pathway responses. Somatosensory evoked potential codes assess responses to stimulation of peripheral nerves, skin sites, or dermatomes.
What is included in the global service?
The global service combines the technical work, including equipment and staff, with the professional interpretation. Bill modifier 26 for the professional component or TC for the technical component when reporting a component.
Should modifier 50 be appended for testing both eyes?
The code is priced as bilateral, and modifier 50 does not increase payment.
What documentation supports 95930?
Document the visual stimulation and responses recorded, the interpretation and report, and the clinical concern prompting the study, such as suspected optic nerve or central visual pathway dysfunction.
Can the technical and professional components be billed separately?
Yes. Modifier TC identifies the technical component, and modifier 26 identifies the professional interpretation. Billing without either modifier represents the global service.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file lines behind this rate
Fee sheets · Coming soon
Put 95930 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist